Which tau PTMs are both disease-specific and druggable with selective small molecule inhibitors? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-13-gap-debate-20260412-094612-a2e3bd09. The debate highlighted promising PTMs like K280 acetylation and O-GlcNAcylation but didn't resolve which modifications can be selectively targeted without affecting physiological t

📊 Related Analysis: Which tau PTMs are both disease-specific and druggable with selective small molecule inhibitors? (neurodegeneration)
Created: 2026-04-18
Download .ipynb